Prevalence
- Authors: Dragunov D.O1, Sokolova A.V1, Latyshev T.V1, Arutyunov G.P1
-
Affiliations:
- Issue: No 3-4 (2016)
- Pages: 49-52
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/272688
- ID: 272688
Cite item
Open Access
Access granted
Abstract
Purpose. Evaluation of detection rate and prevalence of CKD in comorbid patients with risk factors for CKD in outpatient clinical practice. Material and Methods. і000 out-patient medical records were analyzed. The study included ЗЗ7 patients with two diseases, the first of which was arterial hypertension, and the second - coronary artery disease or diabetes mellitus. GFR was calculated using CKD-Ері formula in accordance with national guidelines for CKD. The diagnosis of CKD was verified in accordance with the KDIGO recommendations. Results. The mean age of the patients was 75 ± 7.4 years. Mean estimated GFR using formula CKD-Ері was 77.5 ± 20 ml / min / 1,73m2. Of ЗЗ7 patients enrolled in the study, 43% of patients were diagnosed with CKD, including C2 stage in і8.7% , СЗ in 24% , and C4 - in 0.3% of patients. or for the development of CKD in DM2 patients was 8.24 (95% Cl 4.095 - 16.58; P <0,05). The risk of iii FC stenocardia was higher in patients with CKD: or 2.286 (95% Cl 1.1294.626, P <0.05), but the risk of myocardial infarction in these patients was not high (Or 0.444; 95% Cl 0.251 - 0.789). Conclusion. Despite the high risk of CKD in all examined patients, none was diagnosed with CKD. Probably, this is due to the fact that the majority of patients had a second and third stage CKD, and it is known that these stages in most cases have not any nephrological symptoms, and often the an increase in blood pressure is the only sign.
Full Text
About the authors
D. O Dragunov
Email: tam0ps2211@gmail.com
A. V Sokolova
T. V Latyshev
G. P Arutyunov
References
- Xu R., Zhang L., Zhang P., Wang F., Zuo L., Wang H. Comparison of the prevalence of chronic kidney disease among differentethnicities: Beijing CKD survey and American NHANES. Nephrol. Dial. Transplant. 2009;24(4):1220-1226.
- Coresh J., Astor B.C., Greene T., Eknoyan G., Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 2003;41(1):1-12.
- Свиридова М.С., Ефремова О.А., Камышникова Л.А. Распространенность хронической болезни почек I-III стадий в Белгородской области. Научные ведомости Белгородского государственного университета. Серия: Медицина. Фармация. 2013;4(147),21:182-186.
- Смирнов А.В., Шилов Е.М., Добронравов В.А. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Клиническая нефрология. 2012;4:4-26.
- Inker L.A., Astor B.C., Fox C.H., Isakova T., Lash J.P., Peralta C.A., Kurella Tamura M., Feldman H.I. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD. Am. J. Kidney Dis. 2014;63(5):713-735.
- Gifford F., Kimmitt R., Herath C., Webb D.J., Melville V., Siribaddana S., Eddleston M., Dhaun N. Arterial stiffness & Sri Lankan chronic kidney disease of unknown origin. Sci Rep. 2016;2;6:32599.
- Tabrizi R., Zolala F., Nasirian M., Baneshi M.R., Etminan A., Sekhavati E., Khodadost M., Haghdoost A.A. Estimation of the prevalence of chronic kidney disease: The results of a model based estimation in Kerman, Iran. Med. J. Islam. Repub. Iran. 2016;5;30:338.
- Jafar T. SSA 02-4 DISPARITIES IN HYPERTENSION MANAGEMENT OF CKD IN SOUTH ASIA. J. Hypertens. 2016;34 (1):e2-3.
- Пигарева Ю.А., Авдошина С.В., Дмитрова Т.Б., Ефремовцева М.А., Тигай Ж.Г. Распространенность хронической болезни почек среди пациентов терапевтического стационара. Клиническая нефрология. 2012;3:4-9.
- Антонова Т.Н., Бикбов Б.Т., Галь И.Г., Томилина Н.А. К вопросу о распространенности хронической болезни почек среди пожилых лиц в Москве и ее связи с сердечно-сосудистой патологией. Нефрология и диализ. 2011;13(3):353-354.
Supplementary files
